These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16829540)
41. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation. Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952 [TBL] [Abstract][Full Text] [Related]
42. [Clinical efficacy and safety of emergent percutaneous coronary intervention for vein-grafts in the patients with acute myocardial infarction: comparison between age groups]. Wang Y; Katus AH; Hasse KK; Gai LY; Yang TS; Shen H; Ji D; Chen L; Liu HB; Sun ZJ; Ren YH; Jin QH; Wang Y; Du LS; Li ZJ; Shao RH; Li TD Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):137-41. PubMed ID: 15760520 [TBL] [Abstract][Full Text] [Related]
43. Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention. Araszkiewicz A; Grajek S; Lesiak M; Prech M; Pyda M; Janus M; Cieslinski A Am J Cardiol; 2006 Sep; 98(6):725-8. PubMed ID: 16950171 [TBL] [Abstract][Full Text] [Related]
44. Effect of a distal protection device on epicardial blood flow and myocardial perfusion in primary percutaneous coronary intervention. Zhou BQ; Tahk SJ J Zhejiang Univ Sci B; 2007 Aug; 8(8):575-9. PubMed ID: 17657860 [TBL] [Abstract][Full Text] [Related]
45. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris. Duygu H; Turkoglu C; Kirilmaz B; Turk U J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827 [TBL] [Abstract][Full Text] [Related]
46. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients. Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036 [TBL] [Abstract][Full Text] [Related]
47. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997 [TBL] [Abstract][Full Text] [Related]
48. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome. Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930 [TBL] [Abstract][Full Text] [Related]
49. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention]. Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916 [TBL] [Abstract][Full Text] [Related]
50. Culprit only versus complete coronary revascularization during primary PCI. Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557 [TBL] [Abstract][Full Text] [Related]
51. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825 [TBL] [Abstract][Full Text] [Related]
52. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study. Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926 [TBL] [Abstract][Full Text] [Related]
53. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry. Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155 [TBL] [Abstract][Full Text] [Related]
54. Intravenous versus intracoronary myocardial contrast echocardiography for evaluation of no-reflow after primary percutaneous coronary intervention. Song JM; Lee JH; Kim YH; Kang DH; Song JK; Hong MK; Park SW; Park SJ; Kim YH Echocardiography; 2005 Nov; 22(10):818-25. PubMed ID: 16343164 [TBL] [Abstract][Full Text] [Related]
55. Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. Kusama I; Hibi K; Kosuge M; Nozawa N; Ozaki H; Yano H; Sumita S; Tsukahara K; Okuda J; Ebina T; Umemura S; Kimura K J Am Coll Cardiol; 2007 Sep; 50(13):1230-7. PubMed ID: 17888839 [TBL] [Abstract][Full Text] [Related]
56. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals. Coleman CI; McKay RG; Boden WE; Mather JF; White CM Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084 [TBL] [Abstract][Full Text] [Related]
57. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30). Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E; Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854 [TBL] [Abstract][Full Text] [Related]
58. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease. Taylor AJ; Bobik A; Richards M; Kaye D; Raines G; Gould P; Jennings G Am Heart J; 2004 Aug; 148(2):e10. PubMed ID: 15309013 [TBL] [Abstract][Full Text] [Related]
59. Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction. Niccoli G; Andreotti F; Marzo F; Cecchetti S; Santucci E; D'Amario D; Pafundi T; Cosentino N; Crea F Eur J Clin Invest; 2011 Nov; 41(11):1210-9. PubMed ID: 21492156 [TBL] [Abstract][Full Text] [Related]
60. [Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction]. Wang ZY; Liu N; Lei LC; Ren LH; Ye HM; Peng JJ Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3403-6. PubMed ID: 23327699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]